{
  "params": {
    "ind": "药品及生物科技",
    "sort": "ygc",
    "page": 1,
    "q": "",
    "sig": false,
    "fcf": "",
    "screen": true,
    "big": false,
    "mine": false
  },
  "screen_rule": {
    "ee_lt": 19,
    "ygc_gt": 0.5
  },
  "pages": 1,
  "count": 19,
  "fcf_counts": {
    "all": 19,
    "end": 10,
    "yoy": 1,
    "trend": 12
  },
  "cap_counts": {
    "all": 19,
    "big": 4
  },
  "mine_counts": {
    "all": 19,
    "mine": 0
  },
  "watch_count": 0,
  "watch_updated": null,
  "triggered": 7,
  "details_updated_bj": "2026-10-17 13:54",
  "universe_updated_bj": "2026-10-17 13:49",
  "quotes_updated_bj": "2026-10-17 14:00",
  "quote_source": "腾讯",
  "a_updated_bj": "2026-10-17 14:00",
  "hkd_cny": 0.8517,
  "ah_count": 176,
  "main_period": "2026-06-30",
  "coverage": {
    "2026-06-30": 1995,
    "2025-06-30": 47,
    "2026-03-31": 403,
    "2024-12-31": 15,
    "2026-01-31": 7,
    "2025-12-31": 26,
    "2026-04-30": 15,
    "2025-10-31": 1,
    "2026-02-28": 23,
    "2025-09-30": 4,
    "2025-03-31": 4,
    "2026-09-30": 3,
    "2026-05-31": 8
  },
  "fcf_years": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025"
  ],
  "missing": [],
  "rows": [
    {
      "code": "02325",
      "name": "云康集团",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 0.585,
      "market_cap_yi": 3.1,
      "ev_yi": 3.8,
      "ee": 6.2,
      "loss": false,
      "ygc": 7.04,
      "triggered": true,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 15.28,
        "cash_yi": 14.6,
        "np_ttm_yi": 0.61,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          1.4,
          -1.8,
          2.7,
          2.3,
          2.5
        ],
        "fcf_avg_yi": 1.42,
        "ibd_yi": 6.88,
        "k": 0.995,
        "k_src": "equity",
        "iv_yi": 21.810399999999998
      },
      "revenue_ttm_yi": 5.41,
      "net_margin": 11.3,
      "roe_by_year": {
        "2023": -4.4035,
        "2024": -48.6322,
        "2025": 0.254
      },
      "roe_avg": -17.59,
      "common_equity_yi": 11.5794,
      "pb": 0.27,
      "roe_pb": -65.72,
      "watched": false
    },
    {
      "code": "00950",
      "name": "李氏大药厂",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 1.055,
      "market_cap_yi": 5.3,
      "ev_yi": 15.5,
      "ee": 14.9,
      "loss": false,
      "ygc": 3.51,
      "triggered": false,
      "fcf_growth": [
        "end",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 13.34,
        "cash_yi": 3.16,
        "np_ttm_yi": 1.04,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          1.4,
          2.4,
          0.7,
          1.8,
          2.5
        ],
        "fcf_avg_yi": 1.7600000000000002,
        "ibd_yi": 2.17,
        "k": 1,
        "k_src": "equity",
        "iv_yi": 18.590000000000003
      },
      "revenue_ttm_yi": 13.55,
      "net_margin": 7.7,
      "roe_by_year": {
        "2023": 0.8427,
        "2024": 5.045,
        "2025": 4.9728
      },
      "roe_avg": 3.62,
      "common_equity_yi": 18.4593,
      "pb": 0.29,
      "roe_pb": 12.61,
      "watched": false
    },
    {
      "code": "02877",
      "name": "神威药业",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 7.44,
      "market_cap_yi": 52.4,
      "ev_yi": -0.5,
      "ee": -0.1,
      "loss": false,
      "ygc": 2.97,
      "triggered": true,
      "fcf_growth": [
        "end",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 22.49,
        "cash_yi": 75.38,
        "np_ttm_yi": 8.04,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          6.1,
          9.8,
          7.9,
          8.2,
          9.7
        ],
        "fcf_avg_yi": 8.34,
        "ibd_yi": 3.12,
        "k": 1,
        "k_src": "profit",
        "iv_yi": 155.66
      },
      "revenue_ttm_yi": 26.64,
      "net_margin": 30.2,
      "roe_by_year": {
        "2023": 14.4516,
        "2024": 11.5856,
        "2025": 12.2347
      },
      "roe_avg": 12.76,
      "common_equity_yi": 82.0615,
      "pb": 0.64,
      "roe_pb": 19.98,
      "watched": false
    },
    {
      "code": "06896",
      "name": "金嗓子",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 1.905,
      "market_cap_yi": 12,
      "ev_yi": 12.1,
      "ee": 5.6,
      "loss": false,
      "ygc": 1.98,
      "triggered": true,
      "fcf_growth": [
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 9.35,
        "cash_yi": 9.23,
        "np_ttm_yi": 2.15,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          1.1,
          2.6,
          2.2,
          4.1,
          0.8
        ],
        "fcf_avg_yi": 2.16,
        "ibd_yi": 7.11,
        "k": 1,
        "k_src": "profit",
        "iv_yi": 23.720000000000002
      },
      "revenue_ttm_yi": 9.04,
      "net_margin": 23.8,
      "roe_by_year": {
        "2023": 16.1927,
        "2024": 21.1224,
        "2025": 17.6716
      },
      "roe_avg": 18.33,
      "common_equity_yi": 11.9965,
      "pb": 1,
      "roe_pb": 18.32,
      "watched": false
    },
    {
      "code": "01061",
      "name": "亿胜生物科技",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 2.085,
      "market_cap_yi": 10,
      "ev_yi": 12.3,
      "ee": 5.2,
      "loss": false,
      "ygc": 1.92,
      "triggered": true,
      "fcf_growth": [
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 9.27,
        "cash_yi": 7.01,
        "np_ttm_yi": 2.34,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          1.3,
          0.9,
          1.9,
          2.3,
          1.2
        ],
        "fcf_avg_yi": 1.52,
        "ibd_yi": 3.03,
        "k": 1,
        "k_src": "profit",
        "iv_yi": 19.18
      },
      "revenue_ttm_yi": 15.2,
      "net_margin": 15.4,
      "roe_by_year": {
        "2023": 15.0615,
        "2024": 15.1808,
        "2025": 14.0227
      },
      "roe_avg": 14.76,
      "common_equity_yi": 22.1416,
      "pb": 0.45,
      "roe_pb": 32.67,
      "watched": false
    },
    {
      "code": "08049",
      "name": "吉林长龙药业",
      "l1": "药品及生物科技",
      "l2": "H股 · 创业板",
      "price": 2.48,
      "market_cap_yi": 11.8,
      "ev_yi": 21,
      "ee": 9.6,
      "loss": false,
      "ygc": 1.86,
      "triggered": true,
      "fcf_growth": [
        "end",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 9.23,
        "cash_yi": 0,
        "np_ttm_yi": 2.19,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          1.2,
          1.9,
          2.8,
          2.1,
          3
        ],
        "fcf_avg_yi": 2.2,
        "ibd_yi": 0.01,
        "k": 1,
        "k_src": "profit",
        "iv_yi": 21.99
      },
      "revenue_ttm_yi": 8.98,
      "net_margin": 24.4,
      "roe_by_year": {
        "2023": 9.5844,
        "2024": 11.8489,
        "2025": 11.988
      },
      "roe_avg": 11.14,
      "common_equity_yi": 18.1127,
      "pb": 0.65,
      "roe_pb": 17.1,
      "watched": false
    },
    {
      "code": "00239",
      "name": "白花油",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 2.39,
      "market_cap_yi": 6.3,
      "ev_yi": 4.4,
      "ee": 5,
      "loss": false,
      "ygc": 1.76,
      "triggered": true,
      "fcf_growth": [
        "end",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 1.25,
        "cash_yi": 3.19,
        "np_ttm_yi": 0.87,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          0.6,
          0.4,
          1.3,
          0.7,
          1
        ],
        "fcf_avg_yi": 0.8,
        "ibd_yi": 0.12,
        "k": 1,
        "k_src": "profit",
        "iv_yi": 11.07
      },
      "revenue_ttm_yi": 1.95,
      "net_margin": 44.6,
      "roe_by_year": {
        "2023": 14.2676,
        "2024": 10.5042,
        "2025": 12.5591
      },
      "roe_avg": 12.44,
      "common_equity_yi": 6.3755,
      "pb": 0.99,
      "roe_pb": 12.59,
      "watched": false
    },
    {
      "code": "01666",
      "name": "同仁堂科技",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 3.105,
      "market_cap_yi": 33.9,
      "ev_yi": 25.1,
      "ee": 8.2,
      "loss": false,
      "ygc": 1.57,
      "triggered": true,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 32.99,
        "cash_yi": 47.9,
        "np_ttm_yi": 3.07,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          8.6,
          5.5,
          4.5,
          -2,
          14.3
        ],
        "fcf_avg_yi": 6.180000000000001,
        "ibd_yi": 19.11,
        "k": 0.589,
        "k_src": "profit",
        "iv_yi": 53.35751
      },
      "revenue_ttm_yi": 57.7,
      "net_margin": 5.3,
      "roe_by_year": {
        "2023": 8.8271,
        "2024": 7.4037,
        "2025": 5.4484
      },
      "roe_avg": 7.23,
      "common_equity_yi": 73.043,
      "pb": 0.46,
      "roe_pb": 15.57,
      "watched": false
    },
    {
      "code": "02633",
      "name": "雅各臣科研制药",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 0.96,
      "market_cap_yi": 16.4,
      "ev_yi": 23.6,
      "ee": 8.9,
      "loss": false,
      "ygc": 1.5,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 10.8,
        "cash_yi": 3.27,
        "np_ttm_yi": 2.66,
        "period": "2026-03-31",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          2.8,
          5,
          3.2,
          2.6,
          1.7
        ],
        "fcf_avg_yi": 3.0599999999999996,
        "ibd_yi": 8.04,
        "k": 0.952,
        "k_src": "profit",
        "iv_yi": 24.590159999999994
      },
      "revenue_ttm_yi": 13.86,
      "net_margin": 19.2,
      "roe_by_year": {
        "2023": 10.4512,
        "2024": 12.4688,
        "2025": 12.6485
      },
      "roe_avg": 11.86,
      "common_equity_yi": 20.4491,
      "pb": 0.8,
      "roe_pb": 14.78,
      "watched": false
    },
    {
      "code": "03613",
      "name": "同仁堂国药",
      "l1": "药品及生物科技",
      "l2": "红筹股",
      "price": 5.75,
      "market_cap_yi": 41,
      "ev_yi": 25.7,
      "ee": 8.1,
      "loss": false,
      "ygc": 1.29,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 2.37,
        "cash_yi": 18.75,
        "np_ttm_yi": 3.17,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          6.3,
          4.5,
          4,
          -2.4,
          7.1
        ],
        "fcf_avg_yi": 3.9,
        "ibd_yi": 1.09,
        "k": 0.935,
        "k_src": "profit",
        "iv_yi": 52.9771
      },
      "revenue_ttm_yi": 11.95,
      "net_margin": 26.5,
      "roe_by_year": {
        "2023": 14.4664,
        "2024": 12.5985,
        "2025": 9.614
      },
      "roe_avg": 12.23,
      "common_equity_yi": 35.2175,
      "pb": 1.16,
      "roe_pb": 10.5,
      "watched": false
    },
    {
      "code": "01530",
      "name": "三生制药",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 14.47,
      "market_cap_yi": 309.7,
      "ev_yi": 290.9,
      "ee": 3.5,
      "loss": false,
      "ygc": 1.05,
      "triggered": false,
      "fcf_growth": [
        "end",
        "yoy",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 48.14,
        "cash_yi": 67.85,
        "np_ttm_yi": 82.71,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          4.3,
          11.6,
          13.8,
          22.4,
          91.3
        ],
        "fcf_avg_yi": 28.679999999999996,
        "ibd_yi": 13.87,
        "k": 0.955,
        "k_src": "profit",
        "iv_yi": 325.44489999999996
      },
      "revenue_ttm_yi": 178.66,
      "net_margin": 46.3,
      "roe_by_year": {
        "2023": 11.4931,
        "2024": 14.1861,
        "2025": 39.781
      },
      "roe_avg": 21.82,
      "common_equity_yi": 275.191,
      "pb": 1.13,
      "roe_pb": 19.39,
      "watched": false
    },
    {
      "code": "01513",
      "name": "丽珠医药",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 21.26,
      "market_cap_yi": 218.7,
      "ev_yi": 233.9,
      "ee": 14,
      "loss": false,
      "ygc": 1,
      "triggered": false,
      "fcf_growth": [
        "end",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 89.94,
        "cash_yi": 73.51,
        "np_ttm_yi": 16.74,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          5.9,
          18.3,
          24.3,
          24.1,
          25.7
        ],
        "fcf_avg_yi": 19.66,
        "ibd_yi": 34.4,
        "k": 0.924,
        "k_src": "profit",
        "iv_yi": 217.79604
      },
      "revenue_ttm_yi": 107.48,
      "net_margin": 15.6,
      "roe_by_year": {
        "2023": 13.9954,
        "2024": 14.7723,
        "2025": 14.5816
      },
      "roe_avg": 14.45,
      "common_equity_yi": 133.6583,
      "pb": 1.64,
      "roe_pb": 8.83,
      "watched": false
    },
    {
      "code": "00690",
      "name": "联康生物科技集团",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 0.067,
      "market_cap_yi": 3.4,
      "ev_yi": 3.4,
      "ee": 8,
      "loss": false,
      "ygc": 0.89,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 1.36,
        "cash_yi": 1.38,
        "np_ttm_yi": 0.42,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          0,
          0.2,
          0.4,
          0.3,
          0.3
        ],
        "fcf_avg_yi": 0.24000000000000005,
        "ibd_yi": 0.74,
        "k": 1,
        "k_src": "equity",
        "iv_yi": 3.04
      },
      "revenue_ttm_yi": 4.84,
      "net_margin": 8.7,
      "roe_by_year": {
        "2023": 31.3666,
        "2024": 28.4047,
        "2025": 25.2613
      },
      "roe_avg": 28.34,
      "common_equity_yi": 3.8973,
      "pb": 0.87,
      "roe_pb": 32.49,
      "watched": false
    },
    {
      "code": "00867",
      "name": "康哲药业",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 10.2,
      "market_cap_yi": 211.4,
      "ev_yi": 201.6,
      "ee": 13.1,
      "loss": false,
      "ygc": 0.89,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 15.93,
        "cash_yi": 25.72,
        "np_ttm_yi": 15.34,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          23.1,
          30.3,
          21.8,
          8.1,
          2.4
        ],
        "fcf_avg_yi": 17.14,
        "ibd_yi": 8.83,
        "k": 1,
        "k_src": "profit",
        "iv_yi": 188.29
      },
      "revenue_ttm_yi": 87.11,
      "net_margin": 17.6,
      "roe_by_year": {
        "2023": 15.9482,
        "2024": 10.1772,
        "2025": 8.8343
      },
      "roe_avg": 11.65,
      "common_equity_yi": 179.4692,
      "pb": 1.18,
      "roe_pb": 9.89,
      "watched": false
    },
    {
      "code": "01681",
      "name": "康臣药业",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 15.68,
      "market_cap_yi": 111.9,
      "ev_yi": 116.9,
      "ee": 9.9,
      "loss": false,
      "ygc": 0.88,
      "triggered": false,
      "fcf_growth": [
        "end",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 17.7,
        "cash_yi": 12.69,
        "np_ttm_yi": 11.75,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          6.3,
          9,
          7.7,
          9.8,
          11.4
        ],
        "fcf_avg_yi": 8.84,
        "ibd_yi": 2.29,
        "k": 0.996,
        "k_src": "profit",
        "iv_yi": 98.4048
      },
      "revenue_ttm_yi": 36.33,
      "net_margin": 32.3,
      "roe_by_year": {
        "2023": 23.1712,
        "2024": 23.5745,
        "2025": 24.9765
      },
      "roe_avg": 23.91,
      "common_equity_yi": 47.6094,
      "pb": 2.35,
      "roe_pb": 10.17,
      "watched": false
    },
    {
      "code": "02161",
      "name": "健倍苗苗",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 1.6,
      "market_cap_yi": 11.2,
      "ev_yi": 15.5,
      "ee": 8.7,
      "loss": false,
      "ygc": 0.85,
      "triggered": false,
      "fcf_growth": [
        "end",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 5.58,
        "cash_yi": 1.06,
        "np_ttm_yi": 1.78,
        "period": "2026-03-31",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          0.4,
          1.2,
          1.6,
          1.9,
          1.1
        ],
        "fcf_avg_yi": 1.2399999999999998,
        "ibd_yi": 3.48,
        "k": 0.959,
        "k_src": "profit",
        "iv_yi": 9.570819999999998
      },
      "revenue_ttm_yi": 7.37,
      "net_margin": 24.2,
      "roe_by_year": {
        "2023": 13.3385,
        "2024": 19.2197,
        "2025": 18.6008
      },
      "roe_avg": 17.05,
      "common_equity_yi": 9.537,
      "pb": 1.17,
      "roe_pb": 14.52,
      "watched": false
    },
    {
      "code": "06618",
      "name": "京东健康",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 38.56,
      "market_cap_yi": 1047.8,
      "ev_yi": 1070.5,
      "ee": 17.2,
      "loss": false,
      "ygc": 0.68,
      "triggered": false,
      "fcf_growth": [
        "end",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 227.15,
        "cash_yi": 204.46,
        "np_ttm_yi": 62.16,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          29.1,
          36.3,
          45.4,
          43.3,
          101.7
        ],
        "fcf_avg_yi": 51.160000000000004,
        "ibd_yi": 8.75,
        "k": 1,
        "k_src": "equity",
        "iv_yi": 707.3100000000001
      },
      "revenue_ttm_yi": 790.39,
      "net_margin": 7.9,
      "roe_by_year": {
        "2023": 4.5505,
        "2024": 7.9586,
        "2025": 9.324
      },
      "roe_avg": 7.28,
      "common_equity_yi": 614.5611,
      "pb": 1.7,
      "roe_pb": 4.27,
      "watched": false
    },
    {
      "code": "03880",
      "name": "泰德医药",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 20.4,
      "market_cap_yi": 24.6,
      "ev_yi": 19,
      "ee": 11.2,
      "loss": false,
      "ygc": 0.63,
      "triggered": false,
      "fcf_growth": [
        "end",
        "trend"
      ],
      "detail": {
        "total_liabilities_yi": 2.29,
        "cash_yi": 7.88,
        "np_ttm_yi": 1.69,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          0.9,
          0.4,
          0.3,
          1,
          1.4
        ],
        "fcf_avg_yi": 0.8,
        "ibd_yi": 0.31,
        "k": 1,
        "k_src": "profit",
        "iv_yi": 15.57
      },
      "revenue_ttm_yi": 5.51,
      "net_margin": 30.7,
      "roe_by_year": {
        "2023": 21.4331,
        "2024": 20.667,
        "2025": 22.8386
      },
      "roe_avg": 21.65,
      "common_equity_yi": 16.3632,
      "pb": 1.5,
      "roe_pb": 14.4,
      "watched": false
    },
    {
      "code": "02566",
      "name": "九源基因",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 5.23,
      "market_cap_yi": 10.6,
      "ev_yi": 12,
      "ee": 8.5,
      "loss": false,
      "ygc": 0.53,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 4.68,
        "cash_yi": 3.31,
        "np_ttm_yi": 1.4,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          0,
          -0.4,
          0.9,
          0.1,
          1.5
        ],
        "fcf_avg_yi": 0.42000000000000004,
        "ibd_yi": 1.9,
        "k": 1,
        "k_src": "profit",
        "iv_yi": 5.61
      },
      "revenue_ttm_yi": 12.98,
      "net_margin": 10.8,
      "roe_by_year": {
        "2023": 14.3954,
        "2024": 11.4741,
        "2025": 8.7427
      },
      "roe_avg": 11.54,
      "common_equity_yi": 16.8702,
      "pb": 0.63,
      "roe_pb": 18.36,
      "watched": false
    }
  ]
}